Publications of the team untill 2018
Published on 14 October 2020
Body text 1
2018 
Agosta C, Laugier J, Guyon L, Denis J, Bertherat J, Libé R, Boisson B, Sturm N, Feige JJ, Chabre O and Cherradi N
MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
International Journal of Cancer, 2018, 143(4): 944-57
Benlahfid M, Traboulsi W, Sergent F, Benharouga M, Elhattabi K, Erguibi D, Karkouri M, Elattar H, Fadil A, Fahmi Y, Aboussaouira T and Alfaidy N
Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis.
Cancer Biomarkers, 2018, 21(2): 345-354
Berkane N, Liere P, Lefevre G, Alfaidy N, Abi Nahed R, Vincent J, Oudinet JP, Pianos A, Cambourg A, Rozenberg P, Galichon P, Rousseau A, Simon T, Schumacher M, Chabbert-Buffet N and Hertig A
Abnormal steroidogenesis and aromatase activity in preeclampsia.
Placenta, 2018, 69: 40-9
Jardillier R, Chatelain F and Guyon L
Bioinformatics methods to select prognostic biomarker genes from large scale datasets: A review.
Biotechnology Journal, 2018, 13(12): e1800103
Khalil-Mgharbel A, Polena H, Dembele PK, Sohag MMH, Alcaraz JP, Martin DK and Vilgrain I
A biomimetic lipid membrane device reveals the interaction of cancer biomarkers with human serum lipidic moieties.
Biotechnology Journal, 2018: e1800463
Lappas M, McCracken S, McKelvey K, Lim R, James J, Roberts CT, Fournier T, Alfaidy N, Powell KL, Borg AJ, Morris JM, Leaw B, Singh H, Ebeling PR, Wallace EM, Parry LJ, Dimitriadis E and Murthi P
Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction.
Molecular Human Reproduction, 2018, 24(2): 94-109
Liang QX, Wang ZB, Lin F, Zhang CH, Sun HM, Zhou L, Zhou Q, Schatten H, Filhol-Cochet O, Brigitte B, Sun QY and Qian WP
Ablation of beta subunit of protein kinase CK2 in mouse oocytes causes follicle atresia and premature ovarian failure.
Cell Death Disease, 2018, 9(5): 508
Picollet-D’hahan N, Tollance A, Belda Marin C, Liguori L, Marquette C, Filhol-Cochet O, Vilgrain I, Laffitte G, Rivera F, Alcaraz JP, Thélu J, Nicoud O, Moufle-Milot T, Legues M, Bouamrani A, Mombrun A, Gilquin B, Gerbaud S, Obeid P, Kermarrec F, Gidrol X and Martin DK
3D polyelectrolyte scaffolds to mimic exocrine glands: A step towards a prostate-on-chip platform.
The EuroBiotech Journal, 2018, 2(4): 180-195
Polena H, Creuzet J, Dufies M, Sidibé A, Khalil-Mgharbel A, Salomon A, Deroux A, Quesada JL, Roelants C, Filhol O, Cochet C, Blanc E, Ferlay-Segura C, Borchiellini D, Ferrero JM, Escudier B, Négrier S, Pages G and Vilgrain I
The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: A marker of response to antitumoural treatment in metastatic renal cell carcinoma.
British Journal of Cancer, 2018, 118(9): 1179-1188
Reynaud D, Sergent F, Abi Nahed R, Brouillet S, Benharouga M and Alfaidy N
EG-VEGF maintenance over early gestation to develop a pregnancy-induced hypertensive animal model.
Methods in Molecular Biology, 2018, 1710: 317-324
Roelants C, Giacosa S, Pillet C, Bussat R, Champelovier P, Bastien O, Guyon L, Arnoux V, Cochet C and Filhol O
Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma.
Oncotarget, 2018, 9(53): 30066-30078
2017
Abi Nahed R, Reynaud D, Traboulsi W, Ndagijimana S, Dieudonné MN, Hoffmann P, Benharouga M and Alfaidy N
NLRP7 inflammasome is activated in FGR pregnancies: Physiological and physio-pathological implications.
Placenta, 2017, 57(Supplement C): 287
Arvin-Berod M, Desroches-Castan A, Bonte S, Brugière S, Couté Y, Guyon L, Feige JJ, Baussanne I and Demeunynck M
Indolizine-based scaffolds as efficient and versatile tools: Application to the synthesis of biotin-tagged antiangiogenic drugs.
ACS Omega, 2017, 2(12): 9221-9230
Bestgen B, Belaid-Choucair Z, Lomberget T, Le Borgne M, Filhol O and Cochet C
In search of small molecule inhibitors targeting the flexible CK2 subunit interface.
Pharmaceuticals (Basel), 2017, 10(1): Article number 16
de Bourayne M, Gallais Y, El Ali Z, Rousseau P, Damiens MH, Cochet C, Filhol O, Chollet-Martin S, Pallardy M and Kerdine-Römer S
Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizers.
Journal of Leukocyte Biology, 2017, 101(3): 703-715
Burute M, Prioux M, Blin G, Truchet S, Letort G, Tseng Q, Bessy T, Lowell S, Young J, Filhol O and Thery M
Polarity reversal by centrosome repositioning primes cell scattering during epithelial-to-mesenchymal transition.
Developmental Cell, 2017, 40(2): 168-184
Desroches-Castan A, Feige JJ and Cherradi N
ACTH action on messenger RNA stability mechanisms.
Frontiers in Endocrinology, 2017, 8: 3
Duchemin-Pelletier E, Baulard M, Spreux E, Prioux M, Burute M, Mograbi B, Guyon L, Théry M, Cochet C and Filhol O
Stem cell-like properties of CK2β-down regulated mammary cells.
Cancers, 2017, 9(9): Article number 114
Leal-Egaña A, Letort G, Martiel JL, Christ A, Vignaud T, Roelants C, Filhol O and Théry M
The size-speed-force relationship governs migratory cell response to tumorigenic factors.
Molecular Biology of the Cell, 2017, 28(12): 1612-1621
Lema I, Amazit L, Lamribet K, Fagart J, Blanchard A, Lombes M, Cherradi N and Viengchareun S
HuR-dependent editing of a new mineralocorticoid receptor splice variant reveals an osmoregulatory loop for sodium homeostasis.
Scientific Reports, 2017, 7: Article Number: 4835
Rochefort P, Chabaud S, Pierga JY, Tredan O, Brain E, Bidard FC, Schiffler C, Polena H, Khalil-Mgharbel A, Vilgrain I and Bachelot T
Soluble VE-cadherin in metastatic breast cancer: An independent prognostic factor for both progression-free survival and overall survival.
British Journal of Cancer, 2017, 116(3): 356-361
Traboulsi W, Sergent F, Boufettal H, Brouillet S, Slim R, Hoffmann P, Benlahfid M, Zhou QY, Balboni G, Onnis V, Bolze PA, Salomon A, Sauthier P, Mallet F, Aboussaouira T, Feige JJ, Benharouga M and Alfaidy N
Antagonism of EG-VEGF receptors as targeted therapy for Choriocarcinoma progression in vitro and in vivo.
Clinical Cancer Research, 2017, 23(22): 7130-7140
2016
Alfaidy N
Prokineticin1 and pregnancy.
Annales d'Endocrinologie, 2016, 77(2): 101-104
Alfaidy N, Hoffmann P, Gillois P, Gueniffey A, Lebayle C, Garçin H, Thomas-Cadi C, Bessonnat J, Coutton C, Villaret L, Quenard N, Bergues U, Feige JJ, Hennebicq S and Brouillet S
PROK1 level in the follicular microenvironment: A new noninvasive predictive biomarker of embryo implantation.
Journal of Clinical Endocrinology and Metabolism, 2016, 101(2): 435-444
Banse C, Polena H, Stidder B, Khalil-Mgharbel A, Houivet E, Lequerré T, Fardellone P, Le-Loët X, Philippe P, Marcelli C, Vittecoq O and Vilgrain I
Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab.
Joint, Bone, Spine, 2016
Burute M, Prioux M, Blin G, Truchet S, Letort G, Tseng Q, Bessy T, Lowell S, Young J, Filhol O and Théry M
Polarity reversal by centrosome repositioning primes cell scattering during Epithelial-to-Mesenchymal Transition.
Development Cell, 2016
Cherradi N
microRNAs as potential biomarkers in adrenocortical cancer: Progress and challenges.
Frontiers in Endocrinology, 2016, 6: 195
de Bourayne M, Gallais Y, El Ali Z, Rousseau P, Damiens MH, Cochet C, Filhol O, Chollet-Martin S, Pallardy M and Kerdine-Römer S
Protein kinase CK2 controls T-cell polarization through dendritic cell activation in response to contact sensitizers.
Journal of Leukocyte Biology, 2016
Deroux A, Dumestre-Perard C, Khalil-Mgharbel A, Maignan M, Boccon-Gibod I, Fevre MC, Vilgrain I and Bouillet L
BIOBRAD study: The search for biomarkers of bradykinin-mediated angio-oedema attacks.
International Archives of Allergy and Immunoly, 2016, 170(2): 108-114.
Hérodin F, Voir D, Vilgrain I, Courçon M, Drouet M and Boittin FX
Soluble Vascular Endothelial cadherin as a new biomarker of irradiation in highly irradiated baboons with bone marrow protection.
Health Physics, 2016, 110(6): 598-605
Rataj F, Planel S, Desroches-Castan A, Le Douce J, Lamribet K, Denis J, Feige JJ and Cherradi N
The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-Binding Protein TIS11b/BRF1.
Molecular Biology of the Cell, 2016, 27(24): 3841-3854
Sergent F, Hoffmann P, Brouillet S, Garnier V, Salomon A, Murthi P, Benharouga M, Feige JJ and Alfaidy N
Sustained endocrine gland-derived vascular endothelial growth factor levels beyond the first trimester of pregnancy display phenotypic and functional changes associated with the pathogenesis of pregnancy-induced hypertension.
Hypertension, 2016, 68(1): 148-156
2015
Bardin N, Murthi P and Alfaidy N
Normal and pathological placental angiogenesis.
BioMed Research International, 2015, Article ID 354359
Blaise S, Polena H and Vilgrain I
Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunction.
Vascular Medicine, 2015, 20(6): 557-565
Chauvet S, Traboulsi W, Thevenon L, Kouadri A, Feige JJ, Camara B, Alfaidy N and Benharouga M
EG-VEGF, BV8 and their receptors expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508).
American Journal of Physiology. Lung Cellular and Molecular Physiology, 2015, 309(3): L314-L322
Dakouane-Giudicelli M, Brouillet S, Traboulsi W, Torre A, Vallat G, Si Nacer S, Vallée M, Feige JJ, Alfaidy N and de Mazancourt P
Inhibition of human placental endothelial cell proliferation and angiogenesis by netrin-4.
Placenta, 2015, 36(11): 1260-1265
Deloulme JC, Gory-Fauré S, Mauconduit F, Chauvet S, Jonckheere J, Boulan B, Mire E, Xue J, Jany M, Maucler C, Deparis AA, Montigon O, Daoust A, Barbier EL, Bosc C, Deglon N, Brocard J, Denarier E, Le Brun I, Pernet-Gallay K, Vilgrain I, Robinson PJ, Lahrech H, Mann and Andrieux A
Microtubule-associated protein 6 mediates neuronal connectivity through Semaphorin 3E-dependent signalling for axonal growth.
Nature Communications, 2015, 6: 7246
Deroux A, Vilgrain I, Dumestre-Pérard C, Boccon-Gibod I and Bouillet L
Towards a specific marker for acute bradykinin-mediated angioedema attacks: A literature review.
European Journal of Dermatology, 2015, 25(4): 290-295
Desroches-Castan A, Quelard D, Demeunynck M, Constant JF, Dong C, Keramidas M, Coll JL, Barette C, Lafanechere L and Feige JJ
A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras.
Oncotarget, 2015, 6(7): 5382-5411
Engmann O, Giralt A, Gervasi N, Marion-Poll L, Gasmi L, Filhol O, Picciotto M, Gilligan D, Greengard P, Nairn A, Hervé D and Girault JA
DARPP-32 interaction with adducin may mediate rapid environmental effects on striatal neurons.
Nature communications, 2015
Ferrão PM, d'Avila-Levy CM, Araujo-Jorge TC, Degrave WM, Goncalves AD, Garzoni LR, Lima AP, Feige JJ, Bailly S, Mendonça-Lima L and Waghabi MC
Cruzipain activates latent TGF-ß from host cells during T. cruzi invasion.
PLoS One, 2015, 10(5): e0124832
Filhol O, Giacosa S, Wallez Y and Cochet C
Protein kinase CK2 in breast cancer: The CK2β regulatory subunit takes center stage in epithelial plasticity.
Cellular and Molecular Life Sciences, 2015, 72(17): 3305-3322
Garnier V, Traboulsi W, Salomon A, Brouillet S, Fournier T, Winkler C, Desvergne B, Hoffmann P, Zhou QY, Congiu C, Onnis V, Benharouga M, Feige JJ and Alfaidy N
PPARgammacontrols pregnancy outcome through activation of EG-VEGF: New insights into the mechanism of placental development.
American Journal of Physiology. Endocrinology and Metabolism, 2015, 309(4): E357-E369
Levet S, Ouarne M, Ciais D, Coutton C, Subileau M, Mallet C, Ricard N, Bidart M, Debillon T, Faravelli F, Rooryck C, Feige JJ, Tillet E and Bailly S
BMP9 and BMP10 are necessary for proper closure of the ductus arteriosus.
Proceedings of the National Academy of Sciences, 2015, 112(25): E3207-3215
Mallet C, Lamribet K, Giraud S, Dupuis-Girod S, Feige JJ, Bailly S and Tillet E
Functional analysis of endoglin mutations from hereditary hemorrhagic telangiectasia type 1 patients reveals different mechanisms for endoglin loss of function.
Human Molecular Genetics, 2015, 24(1): 1142-1154
Manoharan GB, Enkvist E, Kasari M, Viht K, Zenn M, Prinz A, Filhol O, Herberg FW and Uri A
FRET-based screening assay using small-molecule photoluminescent probes in lysate of cells overexpressing RFP-fused protein kinases.
Analytical Biochemistry, 2015, 481: 10-17
Micoud J, Chauvet S, Ludwig Scheckenbach KE, Alfaidy N, Chanson M and Benharouga M
Involvement of the heterodimeric interface region of the nucleotide binding domain-2 (NBD2) in the CFTR quaternary structure and membrane stability.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015, 1853(10 Pt A): 2420–2431
Murthi P, Brouillet S, Pratt A, Borg A, Kalionis B, Goffin F, Tsatsaris V, Munaut C, Feige J, Benharouga M, Fournier T and Alfaidy N
An EG-VEGF-dependent decrease in homeobox gene NKX3.1 contributes to cytotrophoblast dysfunction: a possible mechanism in human fetal growth restriction.
Molecular Medicine, 2015, 21: 645-656
| | Roelants C, Giacosa S, Duchemin-Pelletier E, Mcleer-Florin A, Tisseyre C, Aubert C, Champelovier P, Boutonnat J, Descotes JL, Rambeaud JJ, Arnoux V, Long LA, Pasquier D, Laramas M, Kassem M, David-Boudet L, Schouttenten L, Bestgen B, Pillet C, Cochet C and Filhol O
Dysregulated expression of protein kinase CK2 in renal cancer In Protein kinase CK2 function in normal and disease states. Editors: Ahmed Khalil, Issinger Olaf-Georg, Szyszka Ryszard (Eds.), Springer, 2015, 12: pp 241-257 |
Traboulsi W, Brouillet S, Sergent F, Boufettal H, Samouh N, Aboussaouira T, Hoffmann P, Feige JJ, Benharouga M and Alfaidy N
Prokineticins in central and peripheral control of human reproduction.
Hormone Molecular Biology and Clinical Investigation, 2015, 24(2): 73-81
Ulges A, Klein M, Reuter S, Gerlitzki B, Hoffmann M, Grebe N, Staudt V, Stergiou N, Bohn T, Brühl TJ, Muth S, Yurugi H, Rajalingam K, Bellinghausen I, Tuettenberg A, Hahn S, Reißig S, Haben I, Zipp F, Waisman A, Probst HC, Beilhack A, Buchou T, Filhol-Cochet O, Boldyreff B, Breloer M, Jonuleit H, Schild H, Schmitt E and Bopp T
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo.
Nature Immunology, 2015, 16(3): 267-275
Vilmont V, Filhol O, Hesse AM, Couté Y, Hue C, Rémy-Tourneur L, Mistou S, Cochet C and Chiocchia G
Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD).
Biochimica and Biophysica Acta, 2015, 1853(11 Pt A): 2885-2896
Wong MK, Barra NG, Alfaidy N, Hardy DB and Holloway AC
Prenatal nicotine exposure and postnatal health outcomes.
Reproduction, 2015, 150(6): R185-R193
2014
Agosta C, Feige JJ, Bertherat J, Chabre O and Cherradi N
MiR-483-5p and miR-139-5p promote invasion of adrenocortical carcinoma by targeting N-Myc Downstream-Regulated Gene family members.
Annales d'Endocrinologie, 2014, 75(5–6): 273-274
Alfaidy N
Placenta : glande endocrine, cas de l’endocrine gland derived endothelial growth factor (EG-VEGF).
Annales d'Endocrinologie, 2014, 75(5–6): 254-255
Alfaidy N, Hoffmann P, Boufettal H, Samouh N, Aboussaouira T, Benharouga M, Feige JJ and Brouillet S
The multiple roles of EG-VEGF/PROK1 in normal and pathological placental angiogenesis.
BioMed Research International, 2014, 2014: 451906
| | Biard D, Filhol O and Vandenbrouck Y
Tame the expression of the genes with DSIR.
Biofutur, 2014, (360): 52-55 |
Bouillet L, Sidibé A, Polena H, Mannic T, Deroux A, Stidder B, Vittecoq O and Vilgrain I
Instabilité des jonctions endothéliales : biomarqueurs du remodelage vasculaire.
Médecine Sciences, 2014, 30(6-7): 633-635
Bouillet L and Vilgrain I
VE-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacks.
Journal of Allergy and Clinical Immunology, 2014, 134(1): 241
Brouillet S, Dufour A, Prot F, Feige JJ, Equy V, Alfaidy N, Gillois P and Hoffmann P
Influence of the umbilical cord insertion site on the optimal individual birth weight achievement.
BioMed Research International, 2014, 2014: n°341251
Brouillet S, Hoffmann P, Alfaidy N and Feige JJ
[Prokineticins: New regulatory peptides in human reproduction].
Medecine Science (Paris), 2014, 30(3): 274-279
Dakouane-Giudicelli M, Alfaidy N and de Mazancourt P
Netrins and their roles in placental angiogenesis.
BioMed Research International, 2014, 2014: ID 901941
Dunand C, Hoffmann P, Sapin V, Blanchon L, Salomon A, Sergent F, Benharouga M, Sabra S, Guibourdenche J, Lye SJ, Feige JJ and Alfaidy N
Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition.
Biology of Reproduction, 2014, 91(3): 73
Hien YE, Montersino A, Castets F, Leterrier C, Filhol O, Vacher H and Dargent B
CK2 accumulation at the axon initial segment depends on sodium channel Nav1.
Febs Letters, 2014, 588(18): 3403-3408
Holloway AC, Salomon A, Soares MJ, Garnier V, Raha S, Sergent F, Nicholson CJ, Feige JJ, Benharouga M and Alfaidy N
Characterization of the adverse effects of nicotine on placental development: In vivo and in vitro studies.
American Journal of Physiology. Endocrinology and Metabolism, 2014, 306(4): E443-456
Keramidas M, Lavaud J, Sergent F, Hoffmann P, Brouillet S, Feige JJ, Coll JL and Alfaidy N
Noninvasive and quantitative assessment of in vivo fetomaternal interface angiogenesis using RGD-based fluorescence.
BioMed Research International, 2014, 2014: 309082
Levet S, Ricard N, Ciais D, Subileau M, Mallet C, Feige JJ, Vittet D and Bailly S
Specificity and redundancy of BMP9 and BMP10 in postnatal angiogenesis and lymphangiogenesis.
Angiogenesis, 2014, 17(1): 293-294
Moussus M, Loughian C, Fuard D, Courcon M, Gulino-Debrac D, Delanoe-Ayari H and Nicolas A
Intracellular stresses in patterned cell assemblies.
Soft Matter, 2014, 10(14): 2414-2423
Sidibe A, Polena H, Pernet-Gallay K, Razanajatovo J, Mannic T, Chaumontel N, Bama S, Marechal I, Huber P, Gulino-Debrac D, Bouillet L and Vilgrain IY
VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organs.
American Journal of Physiology. Heart and Circulatory Physiology, 2014, 307(3): H455-H463
Sidibe A, Polena H, Razanajatovo J, Mannic T, Chaumontel N, Bama S, Marechal I, Huber P, Gulino-Debrac D, Bouillet L and Vilgrain IY
Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus.
American Journal of Physiology. Heart and Circulatory Physiology, 2014, 307(3): H448-H454
de Thonel A, Hazoume A, Kochin V, Isoniemi K, Jego G, Fourmaux E, Hammann A, Mjahed H, Filhol O, Micheau O, Rocchi P, Mezger V, Eriksson JE, Rangnekar VM and Garrido C
Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells.
Cell Death and Disease, 2014, 5: e1016
Viengchareun S, Lema I, Lamribet K, Keo V, Blanchard A, Cherradi N and Lombes M
Hypertonicity compromises renal mineralocorticoid receptor signaling through Tis11b-mediated post-transcriptional control.
Journal of the American Society of Nephrology, 2014, 25(10): 2213-2221
| |
Vittet D, Brouillet S, Hoffmann P, Alfaidy N and Feige JJ
Cultures de cellules endothéliales. Applications à l’étude de l’angiogenèse In Culture de cellules animales, edited by Barlovatz-Meimon G and Ronot X, Editions Inserm, 2014
|
2013
Alfaidy N, Chauvet S, Andrei S, Salomon A, Saoudi Y, Richaud PR, Aude-Garcia C, Hoffmann P, Andrieux A, Moulis JM, Feige JJ and Benharouga M
Prion protein expression and functional importance in developmental angiogenesis: Role in oxidative stress and copper homeostasis.
Antioxidants and Redox Signaling, 2013, 18(4): 400-411
Boufettal H, Feige JJ, Benharouga M, Aboussaouira T, Nadifi S, Mahdaoui S, Samouh N and Alfaidy N
Rôle potentiel du facteur angiogénique « EG-VEGF » dans les maladies gestationnelles trophoblastiques.
Pathologie Biologie, 2013, 61(5): 178-183
Bouillet L, Baudet AE, Deroux A, Sidibe A, Dumestre-Perard C, Mannic T, Treillard B, Arboleas MA, Chiquet CA, Gulino-Debrac DG and Vilgrain IY
Auto-antibodies to vascular endothelial cadherin in humans: Association with autoimmune diseases.
Laboratory Investigation, 2013, 93(11): 1194-1202
de Bourayne M, Ali ZE, Filhol O, Cochet C, Pallardy M and Kerdine-Römer S
Protein kinase CK2 and JNK control Nrf2 activation in response to skin contact sensitizers in THP1 cells.
Toxicology Letters, 2013, 221(Supplement): S137
Brouillet S, Hoffmann P, Thomas-Cadi C, Bergues U, Feige JJ, Alfaidy N and Hennebicq S
PROK1, biomarqueur de l’implantation embryonnaire ?
[PROK1, prognostic marker of embryo implantation?].
Gynécologie, Obstétrique & Fertilité, 2013, 41(9): 562-565
Brouillet S, Murthi P, Hoffmann P, Salomon A, Sergent F, De Mazancourt P, Dakouane-Giudicelli M, Dieudonné MN, Rozenberg P, Vaiman D, Barbaux S, Benharouga M, Feige JJ and Alfaidy N
EG-VEGF controls placental growth and survival in normal and pathological pregnancies: Case of fetal growth restriction (FGR).
Cellular and Molecular Life Sciences, 2013, 70(3): 511-525
Chabre O, Libe R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ and Cherradi N
Les microARN circulants miR-483-5p et miR-195 prédisent le risque de récidive et de décès des cancers cortico-surrénaliens.
Annales d'Endocrinologie, 2013, 74(4): 269
Chabre O, Libé R, Assie G, Barreau O, Bertherat J, Bertagna X, Feige JJ and Cherradi N
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.
Endocrine-Related Cancer, 2013, 20(4): 579-594
Ciais D, Cherradi N and Feige JJ
Multiple functions of tristetraprolin/TIS11 RNA-binding proteins in the regulation of mRNA biogenesis and degradation.
Cellular and Molecular Life Sciences, 2013, 70(12): 2031-2044
Deshiere A, Duchemin-Pelletier E, Spreux E, Ciais D, Combes F, Vandenbrouck Y, Couté Y, Mikaelian I, Giusiano S, Charpin C, Cochet C and Filhol O
Unbalanced expression of CK2 kinase subunits is sufficient to drive epithelial-to-mesenchymal transition by Snail1 induction.
Oncogene, 2013, 32: 1373-1383
Faure C, Hoffmann P, Salomon A, Garnier V, Sapin V, Blanchon L, Guibourdenche J, Benharouga M, Feige JJ and Alfaidy N
Membranes fœtales humaines, nouvelles sources et cibles du facteur endocrine EG-VEGF : implications physiologiques et physiopathologiques.
Annales d'Endocrinologie, 2013, 74(4): 312
| | Filhol O, Deshiere A and Cochet C
Role of CK2 in the control of cell plasticity in breast carcinoma progression In Protein kinase CK2 Edited by Pinna LA, Willey. Wiley-IUBMB Series on Biochemistry and Molecular Biology, 2013, pp 363-377 |
Garnier V, Salomon A, Fournier T, Sergent F, Hoffmann P, Feige JJ and Alfaidy N
Contribution à la compréhension du mécanisme de régulation de l’invasion trophoblastique par PPARgamma : implication de l’EG-VEGF.
Annales d'Endocrinologie, 2013, 74(4): 262
Gulino-Debrac D
Mechanotransduction at the basis of endothelial barrier function.
Tissue Barriers, 2013, 1(2): e24180
Holloway A, Salomon A, Raha S, Granier V, Sergent MF, Nicholson CJ, Feige JJ, Benharouga M and Alfaidy N
Effet de l’exposition à la nicotine sur le développement placentaire : étude in vivo et in vitro.
Annales d'Endocrinologie, 2013, 74(4): 262-263
Kaspi E, Guillet B, Piercecchi-Marti MD, Alfaidy N, Bretelle F, Bertaud-Foucault A, Stalin J, Rambeloson L, Lacroix O, Blot-Chabaud M, Dignat-George F and Bardin N
Identification of soluble CD146 as a regulator of trophoblast migration: Potential role in placental vascular development.
Angiogenesis, 2013, 16(2): 329-342
Keramidas M, Josserand V, Feige JJ and Coll JL
Noninvasive and quantitative assessment of in vivo angiogenesis using RGD-based fluorescence imaging of subcutaneous sponges.
Molecular Imaging and Biology, 2013, 15(3): 239-244
Levet S, Ciais D, Merdzhanova G, Mallet C, Zimmers TA, Lee SJ, Navarro FP, Texier I, Feige JJ, Bailly S and Vittet D
Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.
Blood, 2013, 122(4): 598-607
Saraiva RM, Waghabi MC, Vilela MF, Madeira FS, Sperandio da Silva GM, Xavier SS, Feige JJ, Hasslocher-Moreno AM and Araujo-Jorge TC
Predictive value of transforming growth factor-ß1 in Chagas disease: Towards a biomarker surrogate of clinical outcome.
Transactions of the Royal Society of Tropical Medicine and Hygiene, 2013, 107(8): 518-525
Vilgrain I, Sidibé A, Polena H, Cand F, Mannic T, Arboleas M, Boccard S, Baudet A, Gulino-Debrac D, Bouillet L, Quesada JL, Mendoza C, Lebas JF, Pelletier L and Berger F
Evidence for post-translational processing of Vascular Endothelial (VE)-Cadherin in brain tumors: Towards a candidate biomarker.
PLoS One, 2013, 8(12): e80056
2012
Araujo-Jorge TC, Waghabi MC, Bailly S and Feige JJ
The TGF-beta pathway as an emerging target for Chagas disease therapy.
Clinical Pharmacology & Therapeutics, 2012, 92(5): 613-621
Bidart M, Ricard N, Levet S, Samson M, Mallet C, David L, Subileau M, Tillet E, Feige JJ and Bailly S
BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.
Cellular and Molecular Life Sciences, 2012, 69(2): 313-324
Erratum in: Cell Mol Life Sci, 2012, 69(3):485
Bouillet L, Adama S, Mannic T, Subileau M, Gulino-Debrac D, Vittecocq O and Vilgrain I
Un nouveau marqueur d’activité de la polyarthrite rhumatoïde : la VE-cadhérine circulante.
La Revue de Médecine Interne, 2012, 33(Supplement 1): S53
Brouillet S, Hoffmann P, Chauvet S, Salomon A, Chamboredon S, Sergent F, Benharouga M, Feige JJ and Alfaidy N
Revisiting the role of hCG: New regulation of the angiogenic factor EG-VEGF and of its receptors.
Cellular and Molecular Life Sciences, 2012, 69(9): 1537-1550
Brouillet S, Hoffmann P, Feige JJ and Alfaidy N
EG-VEGF: A key endocrine factor in placental development.
Trends in Endocrinology and Metabolism, 2012, 23(10): 501–508
Chervin-Petinot A, Courcon M, Almagro S, Nicolas A, Grichine A, Grunwald D, Prandini MH, Huber P and Gulino-Debrac D
Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and in vitro stabilizes the vascular capillary network.
Journal of Biological Chemistry, 2012, 287(10): 7556-7572 | | |
Deroux A, Baudet A, Chiquet C, Altayrac J, Gallice M, Romanet JP, Gulino D, Vilgrain I and Bouillet L
Caractérisation d’anticorps anti-VE-cadhérine dans la choriorétinopathie de Birdshot.
La Revue de Médecine Interne, 2012, 33, Supplement 2(0): A67
Filhol O, Ciais D, Lajaunie C, Charbonnier P, Foveau N, Vert JP and Vandenbrouck Y
DSIR: Assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes.
PLoS One, 2012, 7(10): e48057
Herbet M, Salomon A, Feige JJ and Thomas M
Acquisition order of Ras and p53 gene alterations defines dictinct adrenocortical tumor phenotypes.
PLoS Genetics, 2012, 8(5): e1002700
| |
Hoffmann P, Brouillet S, Benharouga M, Feige JJ and Alfaidy N
Role of EG-VEGF in human placentation: Physiological and pathological implications In Recent Advances In Research on The Human Placenta, Edited by Zheng J, InTech, 2012, Chap 14, pp 287-306
|
de Oliveira FL, Araujo-Jorge TC, de Souza EM, de Oliveira GM, Degrave WM, Feige JJ, Bailly S and Waghabi MC
Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in chagas disease.
PLoS Neglected Tropical Diseases, 2012, 6(6): e1696
Prudent R, Vassal-Stermann E, Nguyen CH, Pillet C, Martinez A, Prunier C, Barette C, Soleilhac E, Filhol O, Beghin A, Valdameri G, Honore S, Aci-Seche S, Grierson D, Antonipillai J, Li R, Di Pietro A, Dumontet C, Braguer D, Florent JC, Knapp S, Bernard O and Lafanechere L
Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth.
Cancer Research, 2012, 72(17): 4429-4439
Ricard N, Ciais D, Levet S, Subileau M, Mallet C, Zimmers TA, Lee SJ, Bidart M, Feige JJ and Bailly S
BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Blood, 2012, 119(25): 6162-6171
Sidibe A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, Bouillet L, Jan M, Vandhuick T, Le Loet X, Vittecoq O and Vilgrain I
Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage.
Arthritis and Rheumatism, 2012, 64(1): 77-87
Supplementary methods, figures and legends
Singh P, Soon PS, Feige JJ, Chabre O, Zhao JT, Cherradi N, Lalli E and Sidhu SB
Dysregulation of microRNAs in adrenocortical tumors.
Molecular and Cellular Endocrinology, 2012, 351(1): 118-128
Tahtouh T, Elkins JM, Filippakopoulos P, Soundararajan M, Burgy G, Durieu E, Cochet C, Schmid RS, Lo DC, Delhommel F, Oberholzer AE, Pearl LH, Carreaux F, Bazureau JP, Knapp S and Meijer L
Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.
Journal of Medicinal Chemistry, 2012, 55(21): 9312-9330
Tseng Q, Duchemin-Pelletier E, Deshiere A, Balland M, Guillou H, Filhol O and Thery M
Spatial organization of the extracellular matrix regulates cell-cell junction positioning.
Proceedings of the National Academy of Sciences, 2012, 109(5): 1506-1511
Vittet D, Merdzhanova G, Prandini MH, Feige JJ and Bailly S
TGFss1 inhibits lymphatic endothelial cell differentiation from mouse embryonic stem cells.
Journal of Cellular Physiology, 2012, 227(11): 3593-3602
2011
Bouillet L, Mannic T, Arboleas M, Subileau M, Massot C, Drouet C, Huber P and Vilgrain I
Hereditary angioedema: Key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation.
Journal of Allergy and Clinical Immunology, 2011, 128(1): 232-234
Bouillot S, Tillet E, Carmona G, Prandini MH, Gauchez AS, Hoffmann P, Alfaidy N, Cand F and Huber P
Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: EVIDENCE OF SHEDDING UP-REGULATION IN PRE-ECLAMPSIA.
Journal of Biological Chemistry, 2011, 286(17): 15195-15204
Chamboredon S, Ciais D, Desroches-Castan A, Savi P, Bono F, Feige JJ and Cherradi N
Hypoxia-inducible factor-1α mRNA: A new target for destabilization by tristetraprolin in endothelial cells.
Molecular Biology of the Cell, 2011, 22(18): 3666-3678
Chervin-Petinot A, Courcon M, Almagro S, Nicolas A, Grichine A, Grunwald D, Prandini MH, Huber P and Gulino-Debrac D
Eplin interacts with α-catenin and actin filaments in endothelial cells and in vitro stabilizes the vascular capillary network.
Journal of Biological Chemistry, 2011, | | |
Dakouane-Giudicelli M, Alfaidy N, Bayle P, Tassin de Nonneville A, Studer V, Rozenberg P and de Mazancourt P
Hypoxia-inducible factor 1 controls the expression of the uncoordinated-5-B receptor, but not of Netrin-1, in first trimester human placenta.
International Journal of Developmental Biology, 2011, 55(10-12): 981-987
Deshiere A, Duchemin-Pelletier E, Spreux E, Ciais D, Forcet C, Cochet C and Filhol O
Regulation of epithelial to mesenchymal transition: CK2ß on stage.
Molecular and Cellular Biochemistry, 2011, 356(1-2): 11-20
Desroches-Castan A, Cherradi N, Feige JJ and Ciais D
A novel function of Tis11b/BRF1 as a regulator of Dll4 mRNA 3'-end processing.
Molecular Biology of the Cell, 2011, 22(19): 3625-3633
Filhol O and Cochet C
Protein kinases curb cell death.
Science Signaling, 2011, 4(172): pe26
Giusiano S, Cochet C, Filhol O, Duchemin-Pelletier E, Secq V, Bonnier P, Carcopino X, Boubli L, Birnbaum D, Garcia S, Iovanna J and Charpin C
Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays.
European Journal of Cancer, 2011, 47(5): 792-801
Moucadel V, Prudent R, Sautel CF, Teillet F, Barette C, Lafanechere L, Receveur-Brechot V and Cochet C
Antitumoral activity of allosteric inhibitors of Protein kinase CK2.
Oncotarget, 2011, 2(12): 997-1010
Tseng Q, Wang I, Duchemin-Pelletier E, Azioune A, Carpi N, Gao J, Filhol O, Piel M, Thery M and Balland M
A new micropatterning method of soft substrates reveals that different tumorigenic signals can promote or reduce cell contraction levels.
Lab on a Chip, 2011, 11(13): 2231-2240
Ziercher L, Filhol O, Laudet B, Prudent R, Cochet C and Buchou T
Structure-function analysis of the beta regulatory subunit of protein kinase CK2 by targeting embryonic stem cell.
Molecular and Cellular Biochemistry, 2011, 356(1-2): 75-81
2010
Almagro S, Durmort C, Chervin-Pétinot A, Heyraud S, Dubois M, Lambert O, Maillefaud C, Hewat E, Schaal JP, Huber P and Gulino-Debrac D
The motor protein Myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts.
Molecular and Cellular Biology, 2010, 30(7): 1703-1717
Assie G, Louiset E, Sturm N, Rene-Corail F, Groussin L, Bertherat J, Thomas M, Lefebvre H, Feige JJ, Clauser E, Chabre O and Cherradi N
Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal cushing's syndrome.
Journal of Clinical Endocrinology and Metabolism, 2010, 95(10): E253-262
| | |
Benaitreau D, Dos Santos E, Leneveu MC, Alfaidy N, Feige JJ, Demazancourt P, Pecquery R and Dieudonne MN
Effects of adiponectin on human trophoblast invasion.
Journal of Endocrinology, 2010, 207(1): 45-53
Brouillet S, Hoffmann P, Benharouga M, Salomon A, Schaal JP, Feige JJ and Alfaidy N
Molecular characterization of EG-VEGF-mediated angiogenesis: Differential effects on microvascular and macrovascular endothelial Cells.
Molecular Biology of the Cell, 2010, 21(16): 2832-2843
Feige JJ
[Tumor angiogenesis: recent progress and remaining challenges].
Bulletin du Cancer, 2010, 97(11): 1305-1310
Gentil-Dit-Maurin A, Oun S, Almagro S, Bouillot S, Courcon M, Linnepe R, Vestweber D, Huber P and Tillet E
Unraveling the distinct distributions of VE- and N-cadherins in endothelial cells: A key role for p120-catenin.
Experimental Cell Research, 2010, 316(16): 2587-2599
Huillard E, Ziercher L, Blond O, Wong M, Deloulme JC, Souchelnytskyi S, Baudier J, Cochet C and Buchou T
Disruption of CK2ß in embryonic neural stem cells compromises proliferation and oligodendrogenesis in the mouse telencephalon.
Molecular and Cellular Biology, 2010, 30(11): 2737-2749
Lopez-Ramos M, Prudent R, Moucadel V, Sautel CF, Barette C, Lafanechere L, Mouawad L, Grierson D, Schmidt F, Florent JC, Filippakopoulos P, Bullock AN, Knapp S, Reiser JB and Cochet C
New potent dual inhibitors of CK2 and Pim kinases: Discovery and structural insights.
FASEB Journal, 2010, 24(9): 3171-3185
Planel S, Salomon A, Jalinot P, Feige JJ and Cherradi N
A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1.
Oncogene, 2010, 29(45): 5989-6003
Prudent R, Moucadel V, Nguyen CH, Barette C, Schmidt F, Florent JC, Lafanechere L, Sautel CF, Duchemin-Pelletier E, Spreux E, Filhol O, Reiser JB and Cochet C
Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2.
Cancer Research, 2010, 70(23): 9865-9874
Prudent R, Sautel CF and Cochet C
Structure-based discovery of small molecules targeting different surfaces of protein-kinase CK2.
Biochimica et Biophysica Acta - Proteins and Proteomics, 2010, 1804(3): 493-498
Prudent R, Sautel CF, Moucadel V, Laudet B, Filhol O, Cochet C and Conn PM
In vitro and in vivo assays of protein kinase CK2 activity.
Methods in Enzymology, 2010, 485: 597-610
Tseng Q, Deshieres A, Guillou H, Filhol-Cochet O and Thery M
Regulation of mechanical equilibrium in multicellular arrangements.
Biophysical Journal, 2010, 98(3, Supplement 1): 211a-211a
Unlugedik E, Alfaidy N, Holloway A, Lye S, Bocking A, Challis J and Gibb W
Expression and regulation of prostaglandin receptors in the human placenta and fetal membranes at term and preterm.
Reproduction Fertility and Developement, 2010, 22(5): 796-807
Waghabi MC, Coutinho-Silva R, Feige JJ, Higuchi ML, Becker D, Burnstock G and Araujo-Jorge TC
Gap junction reduction in cardiomyocytes following transforming growth factor ß treatment and Trypanosoma cruzi infection.
Memórias do Instituto Oswaldo Cruz, 2010, 104: 1083-1090
2009
Brouillet S, Hoffmann P, Benharouga M, Feige JJ and Alfaidy N
EG-VEGF is a new angiogenic factor in human placenta: Effects on micro and macrovascular endothelial cells.
Reproductive Sciences, 2009, 16: 2
Brouillet S, Hoffmann P, Chamboredon S, Feige JJ and Alfaidy N
Human chorionic gonadotropin (hCG) up-regulates EG-VEGF, PKR1 and PKR2 expression in human placenta: A new physiological loop of regulation.
Reproductive Sciences, 2009, 16: 305
Chabre O, Mazzuco T, Feige JJ and Thomas M
Tumorigenèse corticosurrénalienne et expression illégitime de récepteurs couplés aux protéines G : application d'un modèle animal à une pathologie humaine.
Médecine Clinique endocrinologie et diabète, 2009, Avril 2009: 27-33
David L, Feige JJ and Bailly S
Emerging role of bone morphogenetic proteins in angiogenesis.
Cytokine Growth Factor Reviews, 2009, 20(3): 203-212
Duan H, Cherradi N, Feige JJ and Jefcoate C
cAMP stimulation of the zinc finger protein ZFP36L1/TIS11b post-transcriptionally regulates expression and activity of the steroidogenic acute regulatory (STAR) protein.
Molecular Endocrinology, 2009, 23(4): 497-509
Feige JJ
Angiogenesis in adrenocortical physiology and tumor development.
Annales d'Endocrinologie, 2009, 70(3): 153-155
| |
Feige JJ
Les facteurs de croissance de l'endothélium vasculaire et leurs récepteurs.
In L'Angiogenèse, Collection Thérapie Ciblée des Cancers. A. Kahn Ed, John Libbey Eurotext, Montrouge, France, 2009, pp 2-17
|
Filhol O and Cochet C
Cellular functions of Protein kinase CK2: A dynamic affair.
Cellular and Molecular Life Science, 2009, 66(11-12): 1830-1839
Herbet M, Feige JJ and Thomas M
Insights into the role of genetic alterations in adrenocortical tumorigenesis.
Molecular and Cellular Endocrinology, 2009, 300(1-2): 169-174
Heyraud S, Jaquinod M, Durmort C, Concord E, Schaal JP, Huber P and Gulino-Debrac D
Contribution of annexin II to the architecture of mature endothelial adherens junctions.
Molecular and Cellular Biology, 2008, 28(5): 1657-1668
Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ and Alfaidy N
Role of EG-VEGF in human placentation: Physiological and pathological implications.
Journal of Cellular and Molecular Medicine, 2009, 13(8b): 2224-2235
Holland Z, Prudent R, Reiser JB, Cochet C and Doerig C
Functional analysis of protein kinase CK2 of the human malaria parasite Plasmodium falciparum.
Eukaryotic Cell, 2009, 8(3): 388-397
| |
Mazzuco TL, Chabre O, Feige JJ and Thomas M
Luteinizing hormone receptor expression in human adrenal glands. In: Gonadal and non-gonadal actions of gonadotropins. A Kumar, CV Rao, PK Chaturvedi, A Halder and N Rahman (eds), Narosa Publishing House, India, 2009, pp 87-97
|
Petrik JJ, Gerstein HC, Cesta CE, Kellenberger LD, Alfaidy N and Holloway AC
Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine.
Endocrine, 2009, 36(2): 281-290
Prudent R and Cochet C
New protein kinase CK2 inhibitors: Jumping out of the catalytic box.
Chemistry and Biology, 2009, 16(2): 112-120
Taveau JC, Dubois M, Le Bihan O, Trepout S, Almagro S, Hewat E, Durmort C, Heyraud S, Gulino-Debrac D and Lambert O
Structure of artificial and natural VE-cadherinbased adherens junctions.
Biochemical Society Transaction, 2008, 36(Pt 2): 189-193
Viengchareun S, Kamenicky P, Teixeira M, Butlen D, Meduri G, Blanchard-Gutton N, Kurschat C, Lanel A, Martinerie L, Sztal-Mazer S, Blot-Chabaud M, Ferrary E, Cherradi N and Lombes M
Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.
Molecular Endocrinology, 2009, 23(12): 1948-1962
Waghabi MC, Coutinho-Silva R, Feige JJ, Higuchi ML, Becker D, Burnstock G and Araujo-Jorge TC
Gap junction reduction in cardiomyocytes following transforming growth factor ß treatment and Trypanosoma cruzi infection.
Memórias do Instituto Oswaldo Cruz, 2009, 104(8): 1083-1090
Waghabi MC, de Souza EM, de Oliveira GM, Keramidas M, Feige JJ, Araújo-Jorge TC and Bailly S
Pharmacological inhibition of transforming growth factor beta signalling decreases infection and prevents heart damage in acute chagas disease.
Antimicrobial Agents Chemotherapy, 2009, 53(11): 4694-4701
2008
Araujo-Jorge TC, Waghabi MC, Soeiro MD, Keramidas M, Bailly S and Feige JJ
Pivotal role for TGF-ß in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.
Cytokine and Growth Factor Reviews, 2008, 19(5-6): 405-413
Bibert S, Ayari H, Riveline D, Concord E, Hermant B, Vernet T and Gulino-Debrac D
Establishment of cell-cell junctions depends on the oligomeric states of VE-cadherin.
Journal of Biochemistry, 2008, 143(6):821-832
Deshiere A, Ciais D, Cochet C and Filhol O
Epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of Protein-kinase CK2.
Bulletin du Cancer, 2008, 95: S83-S83
Deshiere A, Theis-Febvre N, Martel V, Cochet C and Filhol O
Protein kinase CK2 and cell polarity.
Molecular and Cellular Biochemistry, 2008, 316(1-2): 107-113
Heyraud S, Jaquinod M, Durmort C, Concord E, Schaal JP, Huber P and Gulino-Debrac D
Contribution of annexin II to the architecture of mature endothelial adherens junctions.
Molecular and Cellular Biology, 2008, 28(5): 1657-1668
Keramidas M, Faudot C, Cibiel A, Feige JJ and Thomas M
Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells.
Journal of Endocrinology, 2008 , 196(3): 473-482
Laudet B, Moucadel V, Prudent R, Filhol O, Wong YS, Royer D and Cochet C
Identification of chemical inhibitors of protein-kinase CK2 subunit interaction.
Molecular and Cellular Biochemistry, 2008, 316(1-2): 63-69
Lemmens L, Urbach S, Prudent R, Cochet C, Baldacci G and Hughes P
Phosphorylation of the C subunit (p66) of human DNA polymerase δ.
Biochemical and Biophysical Research Communications, 2008, 367(2): 264-270
Monnier J, Piquet-Pellorce C, Feige JJ, Musso O, Clement B, Turlin B, Theret N and Samson M
Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.
World Journal of Gastroenterology, 2008, 14(8): 1182-1191
Prudent R, Hasenknopf B and Cochet C
A new class of inorganic CK2 inhibitors.
Medecine Sciences (Paris), 2008, 24(12): 1012-1014
Prudent R, Moucadel V, Laudet B and Cochet C
Novel potent and selective inhibitors of protein kinase CK2.
Bulletin du Cancer, 2008, 95: S66-S66
Prudent R, López-Ramos M, Moucadel V, Barette C, Grierson D, Mouawad L, Florent JC, Lafanechère L, Schmidt F and Cochet C
Salicylaldehyde derivatives as new protein ikinase CK2 inhibitors.
Biochimica et Biophysica Acta (BBA) - General Subjects, 2008, 1780(12): 1412-1420
| | Prudent R, Moucadel V, Laudet B, Barette C, Lafanechère L, Hasenknopf B, Li J, Bareyt S, Lacôte E, Thorimbert S, Malacria M, Gouzerh P and Cochet C
Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.
Chemistry and Biology, 2008, 15(7): 683-692 |
Prudent R, Moucadel V, Lopez-Ramos M, Aci S, Laudet B, Mouawad L, Barette C, Einhorn J, Einhorn C, Denis JN, Bisson G, Schmidt F, Roy S, Lafanechere L, Florent JC and Cochet C
Expanding the chemical diversity of CK2 inhibitors.
Molecular and Cellular Biochemistry, 2008, 316(1-2): 71-85
Stipanovich A, Valjent E, Matamales M, Nishi A, Ahn JH, Maroteaux M, Bertran-Gonzalez J, Brami-Cherrier K, Enslen H, Corbille AG, Filhol O, Nairn AC, Greengard P, Herve D and Girault JA
A phosphatase cascade by which rewarding stimuli control nucleosomal response.
Nature, 2008, 453(7197): 879-884
Taveau JC, Dubois M, Le Bihan O, Trépout S, Almagro S, Hewat E, Durmort C, Heyraud S, Gulino-Debrac D and Lambert O
Structure of artificial and natural VE-cadherin-based adherens junctions.
Biochemical Society Transaction, 2008, 36(Pt 2): 189-193
2007
Assrir N, Filhol O, Galisson F and Lipinski M
HIRIP3 is a nuclear phosphoprotein interacting with and phosphorylated by the serine-threonine kinase CK2.
Biological Chemistry, 2007, 388(4): 391-398
Cherradi N, Thomas M, Ciais D, Keramidas M and Feige JJ
Hormonal regulation of VEGF expression and microvascularization In Angiogenesis in endocrine tissues, Edited by Vilgrain I and Feige JJ, Research Signpost, 2007, pp 121-129
Donadio S, Alfaidy N, De Keukeleire B, Micoud J, Feige JJ, Challis JR and Benharouga M
Expression and localization of cellular prion and COMMD1 proteins in human placenta throughout pregnancy.
Placenta, 2007, 28(8-9): 907-911
Hewat EA, Durmort C, Jacquamet L, Concord E and Gulino-Debrac D
Architecture of the VE-cadherin hexamer.
Journal of Molecular Biology, 2007, 365(3): 744-751
Hoffmann P, Feige JJ and Alfaidy N
Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.
Placenta, 2007, 28(10): 1049-1058
Laramas M, Pasquier D, Filhol O, Ringeisen F, Descotes JL and Cochet C
Nuclear localization of protein kinase CK2 catalytic subunit (CK2α) is associated with poor prognostic factors in human prostate cancer.
European Journal of Cancer, 2007, 43(5): 928-934
Laudet B, Barette C, Dulery V, Renaudet O, Dumy P, Metz A, Prudent R, Deshiere A, Dideberg O, Filhol O and Cochet C
Structure-based design of small peptide inhibitors of protein-kinase CK2 subunit interaction.
Biochemical Journal, 2007, 408(3): 363-373
Laudet B, Prudent R, Filhol O and Cochet C
Therapeutic agents targeting protein-protein interactions: Myth or reality?
Medecine Sciences (Paris), 2007, 23(3): 273-278
Mazzuco TL, Chabre O, Feige JJ and Thomas M
Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis.
Molecular and Cellular Endocrinology, 2007, 265-266C: 23-28
Mazzuco TL, Thomas M, Martinie M, Cherradi N, Sturm N, Feige JJ and Chabre O
Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.
Arquivos Brasileiros de Endocrinologia & Metabologia, 2007, 51(9): 1452-1462
Medina-Palazon C, Gruffat H, Mure F, Filhol O, Vingtdeux-Didier V, Drobecq H, Cochet C, Sergeant N, Sergeant A and Manet E
Protein Kinase CK2 phosphorylation of EB2 regulates its function in the production of EBV infectious viral particles.
Journal of Virology, 2007, 81(21): 11850-11860
Vilgrain I and Feige JJ
Angiogenesis in endocrine tissues.
Research Signpost, 2007
Vittet D and Feige JJ
Lymphangiogenesis and tumor progression.
Bulletin du Cancer, 2007, 94(10): 881-886
Waghabi MC, Keramidas M, Calvet CM, Meuser M, Soeiro MD, Mendonca-Lima L, Araujo-Jorge TC, Feige JJ and Bailly S
SB-431542, a transforming growth factor ß inhibitor, impairs Trypannosoma cruzi infection in cardiomyocytes and parasite cycle completion.
Antimicrobial Agents and Chemotheraphy, 2007, 51(8): 2905-2910
Wallez Y, Cand F, Wernstedt C, Cruzalegui F, Souchelnytskyi S, Vilgrain I and Huber P
Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: Identification of tyrosine 685 as the unique target site.
Oncogene, 2007, 26(7): 1067-107
2006
Cherradi N, Lejczak C, Desroches-Castan A and Feige JJ
Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.
Molecular Endocrinology, 2006, 20(4): 916-930
Cheusova T, Khan MA, Schubert SW, Gavin AC, Buchou T, Jacob G, Sticht H, Allende J, Boldyreff B, Brenner HR and Hashemolhosseini S
Casein kinase 2-dependent serine phosphorylation of MuSK regulates acetylcholine receptor aggregation at the neuromuscular junction.
Genes and Development, 2006, 20(13): 1800-1816
Hoffmann P, Feige JJ and Alfaidy N
Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy.
Endocrinology, 2006, 147(4): 1675-1684
Laudet B, Prudent R, Dideberg O, Filhol O and Cochet C
Développement d'un nouvel inhibiteur de la protéine kinase CK2 : un peptide synthétique dérivé de l'interface entre ses deux sous-unités.
Bulletin du Cancer, 2006, 93: S74-75
Laramas M, Pasquier D, Filhol O, Ringeisen F, Descotes JL and Cochet C
Étude immunohistologique de l'expression et de la localisation subcellulaire de la CK2 sur 131 biopsies d'adénocarcinome de prostate : corrélation à des facteurs de mauvais pronostic.
Bulletin du Cancer, 2006, 93: S131
Martel V, Filhol O, Colas P and Cochet C
p53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2.
Oncogene, 2006, 25(56): 7343-7353
Mazzuco TL, Chabre O, Feige JJ and Thomas M
Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features.
Journal of Clinical Endocrinology and Metabolism, 2006, 91(1): 196-203
Mazzuco TL, Chabre O, Sturm N, Feige JJ and Thomas M
Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model.
Endocrinology, 2006, 147(2): 782-790
Podlovni H, Ovadia O, Kisliouk T, Klipper E, Zhou QY, Friedman A, Alfaidy N and Meidan R
Differential expression of prokineticin receptors by endothelial cells derived from different vascular beds: A physiological basis for distinct endothelial function.
Cellular Physiology and Biochemistry, 2006, 18(6): 315-326
Wallez Y, Vilgrain I and Huber P
Angiogenesis: The VE-cadherin switch.
Trends in Cardiovascular Medicine, 2006, 16(2): 55-59
2005
Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X and Gimenez-Roqueplo AP
Genetic testing in pheochromocytoma or functional paraganglioma.
Journal of Clinical Oncology, 2005, 23(34): 8812-8818
Blond O, Jensen HH, Buchou T, Cochet C, Issinger OG and Boldyreff B
Knocking out the regulatory beta subunit of protein kinase CK2 in mice: Gene dosage effects in ES cells and embryos.
Molecular and Cellular Biochemistry, 2005, 274(1-2): 31-37
de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin PF, Baudin E, Berger F, Gicquel C, Chabre O and Feige JJ
Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy.
Journal of Clinical Endocrinology and Metabolism, 2005, 90(3): 1819-1829
Dubois C, Jankowski A, Gay-Jeune C, Chabre O, Pasquier D and Ferretti G
Imaging of adrenal ganglioneuroma: a case report.
Journal of Radiology, 2005, 86(6 Pt 1): 659-662
Greenaway J, Gentry P, Feige JJ, Lamarre J and Petrik JJ
Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development.
Biology of Reproduction, 2005, 72(5): 1071-1078
Hera R*, Keramidas M*, Peoc’H M, Mouillon M, Romanet JP and Feige JJ (*equal contributors)
Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration.
American Journal of Ophtalmology, 2005, 139: 589-559
Huber P, Mallet C, Faure E, Rampon C, Féraud O, Bouillot S and Vilgrain I
ACTH depletion represses VE-cadherin transcription in mouse adrenal endothelium in vivo.
Journal of Molecular Endocrinology, 2005, 34(1): 127-137
Hudry-Clergeon H, Stengel D, Ninio E and Vilgrain I
Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase.
Faseb Journal, 2005, 19(6): 512-520
Lambeng N, Wallez Y, Rampon C, Cand F, Christé G, Gulino Debrac D, Vilgrain I and Huber P
VE-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues.
Circulation Research, 2005, 96(3): 384-391
Schaack B, Reboud J, Combe S, Fouqué B, Berger F, Boccard S, Filhol-Cochet O and Chatelain F
A "DropChip" cell array for DNA and siRNA transfection combined with drug screening.
NanoBiotechnology, 2005, 1: 166-194
Theis-Febvre N, Martel V, Laudet B, Souchier C, Grunwald D, Cochet C and Filhol O
Highlighting protein kinase CK2 movement in living cells.
Molecular and Cellular Biochemistry, 2005, 274(1-2): 15-22
Waghabi MC, Keramidas M, Feige JJ, Araujo-Jorge TC and Bailly S
Activation of transforming growth factor beta by Trypanosoma cruzi.
Cellular Microbiology, 2005, 7(4): 511-517
Waghabi MC, Keramidas M, Bailly S, Degrave W, Mendonca-Lima L, Soeiro Mde N, Meirelles Mde N, Paciornik S, Araujo-Jorge TC and Feige JJ
Uptake of host cell transforming growth factor-ß by Trypanosoma cruzi amastigotes in cardiomyocytes: Potential role in parasite cycle completion.
American Journal of Pathology, 2005, 167(4): 993-1003
2004
Baguet J, Hammer L, Mazzuco T, Chabre O, Mallion J, Sturm N and Chaffanjon P
Circumstances of discovery of phaeochromocytoma: A retrospective study of 41 consecutive patients.
European Journal of Endocrinology, 2004, 150(5): 681-686
Bronner C, Trotzier M, Filhol O, Cochet C, Rochette-Egly C, Schiller-Guinard M, Klein J and Mousli M
The anti-apoptotic protein ICBP90 is a target for protein kinase CK2.
Annals of the New York Academy of Science, 2004, 1030: 355-360
Chanson P, Gueydan M, Mazzuco T, Sonnet E and Coutant R
Déficit en GH, traitement par GH : morceaux choisis de 2003
Médecine Clinique Endocrinologie & Diabète, 2004, 2: 61-70
Ciais D, Cherradi N, Bailly S, Grenier E, Berra E, Pouyssegur J, Lamarre J and Feige JJ
Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b.
Oncogene, 2004, 23(53): 8673-8680
Filhol O, Martiel JL and Cochet C
Protein kinase CK2: A new view of an old molecular complex.
Embo Reports, 2004, 5(4): 351-355
Filhol O, Benitez MJ and Cochet C
A zinc ribbon motif is essential for the formation of functional tetrameric protein kinase CK2 in Zinc finger proteins: From atomic contact to cellular functions (2004), edited by Shino-Iuchi and Kuldell N, Bioscience pp 124-129
De Fraipont F, Keramidas M, El Atifi M, Chambaz EM, Berger F and Feige JJ
Expression of the Thrombospondin 1 Fragment 167-569 in C6 Glioma cells stimulates tumorigenicity despite reduced neovascularization.
Oncogene, 2004, 23: 3642-3649
Gingerich TJ, Feige JJ and LaMarre J
AU-rich elements and the control of gene expression through regulated mRNA stability.
Animal Health Research Reviews, 2004, 5: 49-63
Keramidas M, Feige JJ and Thomas M
Coordinated regression of adrenocortical endocrine and endothelial compartments under adrenocorticotropin deprivation.
Endocrine Research, 2004, 30: 543-549
Roosbeek S, Peelman F, Verhee A, Labeur C, Caster H, Lensink M, Cirulli C, Grooten J, Cochet C, Vandekerckhove J, Amoresano A, Chimini G, Tavernier J and Rosseneu M
Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter.
Journal of Biological Chemistry, 2004, 279(36): 37779-37788
Thomas M*, Keramidas M*, Monchaux E and Feige JJ (*equal contributors)
Dual hormonal regulation of endocrine tissue mass and vasculature by adrenocorticotropin in the adrenal cortex.
Endocrinology, 2004, 145(9): 4320-4329
2003
Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger O-G and Boldyreff B
Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality.
Molecular And Cellular Biology, 2003, 23(3): 908-915
Buchou T and Cochet C
Protein kinase CK2: An enzyme that likes to be different.
Medecine Sciences, 2003, 19(6-7): 709-716
Feige JJ
Analyse du transcriptome : intérêt en endocrinologie.
Metabolismes Hormones Diabètes et Nutrition, 2003, VII: 67-71
Feraud O, Mallet C and Vilgrain I
Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: A study of adrenocorticotropin-induced repair.
Endocrinology, 2003, 144(10): 4607-4615
Filhol O, Nueda A, Martel V, Gerber-Scokaert D, Benitez MJ, Souchier C, Saoudi Y and Cochet C
Live-cell fluorescence imaging reveals the dynamics of protein kinase CK2 individual subunits
Molecular Cellular Biology, 2003, 23(3): 975-987
Hornsby P.J, Chen M, Hawks C.L, Huang Q, Sun B, Wang L and Thomas M
Using cell transplantation to investigate genes involved in aging.
Mech. Ageing Dev., 2003, 124: 79-84
Lefournier V, Martinie M, Vasdev A, Bessou P, Passagia J, Labat-Moleur F, Sturm N, Bosson J, Bachelot I and Chabre O
Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing's disease pituitary microadenoma: Influence of catheter position and anatomy of venous drainage.
Journal of Clinical Endocrinology and Metabolism, 2003, 88(1): 196-203
Liakos P, Lenz D, Bernhardt R, Feige JJ and Defaye G
Transforming growth factor beta 1 inhibits aldosterone and cortisol production in the human adrenocortical carcinoma cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression.
Journal of Endocrinology, 2003, 176: 69-82
Mallet C, Feraud O, Ouengue Mbele G, Gaillard I, Sappay N, Vittet D and Vilgrain I
Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: A protective role of ACTH.
American Journal of Physiology - Endocrinology and Metabolism, 2003, 284(1): E156-67
Theis-Febvre N, Filhol O, Froment C, Cazales M, Cochet C, Monsarrat B, Ducommun B and Baldin V
Protein kinase CK2 regulates CDC25B phosphatase activity.
Oncogene, 2003, 22(2): 220-232
Thomas M, Hawks C L and Hornsby PJ
Adrenocortical cell trnasplantation in scid mice: The role of the host animals adrenal glands.
Journal of Steroid Biochemistry and Molecular Biology, 2003, 85: 285-290
Thomas M, Keramidas M, Ciais D and Feige JJ
Angiogenèse hormono-régulée.
Médecine Clinique-endocrinologie and diabète, 2003, 8: 78-82
Thomas M, Keramidas M, Monchaux E and Feige JJ
Role of adrenocorticotropic hormone in the development and maintenance of the adrenal cortical vasculature.
Microscopy Research and Techique, 2003, 61: 247-251
Thomas M, Keramidas M, Ciais D, Monchaux E and Feige JJ
Hormonal regulation of adrenal cortex vascularization.
Angiogenesis, 2003, 6(4): 338-340
Vailhe B, Ciais D and Feige JJ
Cultures de cellules endothéliales. Applications à l’étude de l’angiogenèse.
In Culture de cellules animales. G. Barlovatz-Meimon and M. Adolphe Eds, Editions INSERM, 2003, pp629-664
Vailhe B and Feige JJ
Thrombospondins as anti-angiogenic therapeutic agents.
Current Pharmaceutical Design, 2003, 9, 583-588
2002
Araujo-Jorge TC, Waghabi M.C, Hasslocher-Moreno A, Xavier S.S, Higuchi ML, Keramidas M, Bailly S and Feige JJ
Implication of transforming growth factor ß in Chagas’ disease cardiomyopathy.
Journal of Infectious Diseases, 2002, 186: 1823-1828
Chinn AM, Ciais D, Bailly S, Chambaz EM, LaMarre J and Feige JJ
Identification of two novel ACTH-responsive genes encoding manganese-dependent superoxide dismutase (SOD2) and the zinc finger protein TIS11b [tetradecanoyl phorbol acetate (TPA)-inducible sequence 11b.
Molecular Endocrinology, 2002, 16: 1417-1427
De Fraipont F, Lemoigne G, Defaye G, El Atifi M, Berger F, Houlgatte R, Gicquel C, Plouin PF, Bertagna X, Chabre O and Feige JJ
Transcription profiling of benign and malignant adrenal tumors by cDNA macro-array analysis.
Endocrine Research, 2002, 28: 785-786
Hornsby P.J, Yang L and Thomas M
Adrenocortical cell proliferation in a cell transplantation model: the role of SV40 T antigen.
Endocrine Research, 2002, 28: 777-783
Maia M, Vivier J, Hue D, Durand P, Feige JJ and Defaye G
Expression of the melanocortin receptors MC2-R (ACTH-receptor) and MC5-R during embryonic development of ovine adrenals.
Endocrine Research, 2002, 28: 631-635
Petrik JJ, Gentry PA, Feige JJ and LaMarre J
Regulation of thrombospondin-1 and –2 and their cell surface receptor CD36 during rat follicular development and formation of the corpus luteum.
Biology of Reproduction, 2002, 67: 1522-1531
Thomas M, Suwa T, Yang L, Zhao L, Hawks CL and Hornsby PJ
Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: A cell transplantation model using bovine adrenocortical cells.
Neoplasia, 2002, 4: 493-500
Thomas M, Wang X and Hornsby PJ
Human adrenocortical cell xenotransplantation: Model of cotransplantation of human adrenocortical cells and 3T3 cells in scid mice to form vascularized functional tissue and prevent adrenal insufficiency.
Xenotransplantation, 2002, 9: 58-67
Vailhe B, Monchaux E and Feige JJ
Angiogenèse Tumorale- Activateurs et inhibiteurs thérapeutiques.
Médecine Clinique-Endocrinologie and Diabète, 2002, 1: 18-20
Waghabi MC, Coutinho C.M.L, Soeiro MNC, Feige JJ, Keramidas M, Cosson A, Minoprio P, Van Leuven F and Araujo-Jorge TC
Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor-ß levels in mice deficient in a2-macroglobulin.
Infection and Immunity, 2002, 70: 5115-5123
2001
De Fraipont F, Nicholson AC, Feige JJ and Van Meir EG
Thrombospondins and tumor angiogenesis.
Trends in Molecular Medicine, 2001, 7: 401-407
Thomas M, Popnikolov N, Scott C, Smith JR and Hornsby PJ
Contrasting roles of p57Kip2 and p21WAF1/CIP1/SDI1 in transplanted human and bovine adrenocortical cells.
Exp. Cell Res., 2001, 266: 106-113
Vailhe B, Vittet D and Feige JJ
In vitro models of vasculogenesis and angiogenesis
Laboratory Investigation, 2001, 81: 439-452
2000
Boulle N, Gicquel C, Logie A, Christol R, Feige JJ and Le Bouc Y
Mitogenic effects of fibroblast growth factor-2 (FGF-2) on NCI H295R cells: Interactions with IGF-II and IGFBP-2 expression.
Endocrinology, 2000, 141: 3127-3136
Brand C, Nury D, Chambaz EM, Feige JJ and Bailly S
Transcriptional regulation of the StAR protein in the human adrenocortical cell line, H295R, by cAMP and TGFß1.
Endocrine Research, 2000, 26: 1045-1053
Chabre O, Portrat-Doyen S, Chaffanjon P, Vivier J, Liakos P, Labat-Moleur F, Chambaz EM, Morel Y and Defaye G
Bilateral laparoscopic adrenalectormy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice of CYP11B1.
Journal of Clinical Endocrinology and Metabolism, 2000, 85: 4060-4068
Chabre O, Portrat-Doyen S, Vivier J, Morel Y and Defaye G
Two novel splice donor site mutations of CYP11B1 in congenital adrenal hyperplasia due to 11ß-hydroxylase deficiency.
Endocrine Research, 2000, 24: 797-801
De Fraipont F, El Atifi M, Gicquel C, Bertagna X, Chambaz EM and Feige JJ
Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1 and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors. Correlation with genotypic alterations.
Journal of Clinical Endocrinology and Metabolism, 2000, 85, 4734-4741
Feige JJ
Thrombospondins.
in Comprehensive Vascular Biology and Pathology. An Encyclopedic Reference. A. Bikfalvi Ed,Springer-Verlag, Berlin, 2000, pp285-292
Feige JJ and Bailly S
Bases moléculaires de l’angiogenèse.
Bulletin de l'Académie Nationale de Médecine, 2000, 184: 537-545
Gaillard I, Keramidas M, Liakos P, Vilgrain I, Feige JJ and Vittet D
ACTH-regulated expression of vascular endothelial growth factor in the adult bovine adrenal cortex: a possible role in the maintenance of the microvasculature.
Journal of Cellular Physiology, 2000, 185, 226-234
Goddard I, Bouras M, Keramidas M, Hendrick JC, Feige JJ and Benahmed M
Transforming growth factor-ß receptor types I and II in cultured porcine Leyding cells: Expression and hormonal regulation.
Endocrinology, 2000, 141: 2068-2074
Liakos P, Chambaz EM, Feige JJ and Defaye G
Expression and regulation of melanocortin receptor-5 (MC5-R) in the bovine adrenal cortex.
Molecular and Cellular Endocrinology, 2000, 159: 99-107
Tenan M, Fulci G, Albertoni M, El Atifi-Borel M, Desbaillets I, Feige JJ, Pepper M and Van Meir EG
Thrombospondin-1 is down-regulated by anoxia and suppresses tumorigenicity of human gliobastoma cells.
Journal of Experimental Medicine, 2000, 191: 1789-1798
Vittet D, Ciais D, Keramidas M, De Fraipont F and Feige JJ
Paracrine control of the adult adrenal cortex vasculature by vascular endothelial growth factor.
Endocrine Research, 2000, 26: 843-852
Top page